TF Capital
Asia, Shandong, China, Pudong'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.
Investor Profile
TF Capital has backed more than 15 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series A (60%)
- Series B (33%)
- Series C (7%)
Country Focus
- China (53%)
- United States (47%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical
- Biopharma
- Therapeutics
- Life Science
- Oncology
- Neuroscience
- Product Research
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
